Skip to content

To study the effect of Lasuna Rasayana and Murivenna Bandage with Walking Aid in Chronic Knee Osteoarthritis

Single arm clinical trial to assess the effect of Lasuna Rasayana and Murivenna Bandage with Walking Aid in Chronic Knee Osteoarthritis - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073526
Enrollment
29
Registered
2024-09-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee

Interventions

None listed

Sponsors

Dr Meenakshi Chauhan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed knee osteoarthritis patients according to American College of Rheumatology clinical criteria. Patients having Radiological changes of the Bilateral knee in the images by the X-ray Kellgren-Lawrence Index up to grade three. laboratory finding- Erythrocyte Sedimentation Rate (ESR) less than forty millimeter per hour 40years - 70 years of age, irrespective of gender, religion and occupation Patients willing to sign the consent form

Exclusion criteria

Exclusion criteria: Patients having auto-immune related joint disorders like Multiple sclerosis RA Polymyalgia rheumatic Severe joint deformities secondary to any other complaints like rheumatoid arthritis gout People with pre diagnosed systemic illness like Hypothyroidism Metabolic syndrome Ulcerative colitis and other deficiency diseases Septic arthritis infectious arthritis Lactose intolerance Sulphur allergy History of any trauma or fracture to the joints in the previous 6 months Obesity Pregnant or Lactating Mothers Diagnosed cases of carcinoma

Design outcomes

Primary

MeasureTime frame
To assess the changes in the scores of VAS scale and WOMAC scale pre and post intervention Timepoint: 30 days

Secondary

MeasureTime frame
SF 36 QOL questionnaireTimepoint: SF 36 QOL questionnaire assessment at 0th and 31st day

Countries

India

Contacts

Public ContactDr Sreejith.k

Amrita School Of Ayurveda

sreejithk@ay.amrita.edu9446127982

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026